Charles River Laboratories International, Inc. (CRL)
304.96
-5.81
(-1.87%)
USD |
NYSE |
Oct 06, 16:00
305.00
+0.04
(+0.01%)
Pre-Market: 06:40
Charles River Laboratories International Enterprise Value : 17.42B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 17.42B |
| October 05, 2026 | 17.70B |
| October 02, 2026 | 16.72B |
| October 01, 2026 | 16.56B |
| September 30, 2026 | 16.95B |
| September 29, 2026 | 16.99B |
| September 28, 2026 | 16.93B |
| September 25, 2026 | 16.84B |
| September 24, 2026 | 16.92B |
| September 23, 2026 | 16.10B |
| September 22, 2026 | 16.47B |
| September 21, 2026 | 16.18B |
| September 18, 2026 | 16.14B |
| September 17, 2026 | 16.31B |
| September 16, 2026 | 15.92B |
| September 15, 2026 | 15.89B |
| September 14, 2026 | 15.90B |
| September 11, 2026 | 16.15B |
| September 10, 2026 | 15.90B |
| September 09, 2026 | 16.15B |
| September 08, 2026 | 16.27B |
| September 04, 2026 | 16.64B |
| September 03, 2026 | 16.87B |
| September 02, 2026 | 16.79B |
| September 01, 2026 | 16.34B |
| Date | Value |
|---|---|
| August 31, 2026 | 16.62B |
| August 28, 2026 | 16.78B |
| August 27, 2026 | 17.01B |
| August 26, 2026 | 16.95B |
| August 25, 2026 | 17.07B |
| August 24, 2026 | 17.12B |
| August 21, 2026 | 16.96B |
| August 20, 2026 | 16.78B |
| August 19, 2026 | 16.71B |
| August 18, 2026 | 16.19B |
| August 17, 2026 | 16.55B |
| August 14, 2026 | 16.23B |
| August 13, 2026 | 16.29B |
| August 12, 2026 | 16.44B |
| August 11, 2026 | 16.33B |
| August 10, 2026 | 16.09B |
| August 07, 2026 | 15.63B |
| August 06, 2026 | 15.54B |
| August 05, 2026 | 15.31B |
| August 04, 2026 | 14.04B |
| August 03, 2026 | 13.89B |
| July 31, 2026 | 13.96B |
| July 30, 2026 | 14.06B |
| July 29, 2026 | 14.07B |
| July 28, 2026 | 14.34B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 57.08B |
| Medpace Holdings, Inc. | 16.43B |
| Fortrea Holdings, Inc. | 2.925B |
| Champions Oncology, Inc. | 76.91M |
| Avantor, Inc. | 13.83B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.76M |
| Revenue (Quarterly) | 1.004B |
| Total Expenses (Quarterly) | 1.006B |
| EPS Diluted (Quarterly) | -0.0309 |
| Gross Profit Margin (Quarterly) | 36.29% |
| Profit Margin (Quarterly) | -0.08% |
| Earnings Yield | -1.59% |
| Operating Earnings Yield | 3.62% |
| Normalized Earnings Yield | 0.617 |